Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 5:48 pm Sale | 2026-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | VIKING GLOBAL INVESTORS LP | 8,264,607 7.800% | -464,738![]() (-5.32%) | Filing History |
| 2026-05-15 4:33 pm Sale | 2026-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | Venrock Healthcare Capital Partners III, L.P. | 4,319,765 4.200% | -1,356,465![]() (-23.90%) | Filing History |
| 2026-05-15 4:17 pm Sale | 2026-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | Point72 Asset Management, L.P. | 0 0.000% | -4,401,659![]() (Position Closed) | Filing History |
| 2026-05-15 10:07 am Purchase | 2026-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | T. Rowe Price Associates, Inc. | 5,387,783 5.400% | 5,387,783![]() (New Position) | Filing History |
| 2026-05-12 5:05 pm Sale | 2026-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | PFIZER INC PFE | 3,442,940 3.300% | -1,933,404![]() (-35.96%) | Filing History |
| 2026-02-17 6:15 pm Sale | 2025-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | Venrock Healthcare Capital Partners III, L.P. | 5,676,230 5.800% | -920,655![]() (-13.96%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock, Inc. BLK | 5,473,145 5.600% | 1,852,921![]() (+51.18%) | Filing History |
| 2025-11-17 8:17 pm Unchanged | 2025-09-30 | 13G | ORIC PHARMACEUTICALS INC ORIC | The Column Group II, LP | 3,644,118 3.700% | 0 (Unchanged) | Filing History |
| 2025-11-13 6:15 pm Purchase | 2025-09-30 | 13G | ORIC PHARMACEUTICALS INC ORIC | ALKEON CAPITAL MANAGEMENT LLC | 4,504,096 4.600% | 600,000![]() (+15.37%) | Filing History |
| 2025-08-14 5:34 pm Purchase | 2025-06-30 | 13G | ORIC PHARMACEUTICALS INC ORIC | VIKING GLOBAL INVESTORS LP | 8,729,345 9.990% | 2,156,645![]() (+32.81%) | Filing History |
| 2025-08-14 4:54 pm Purchase | 2025-06-30 | 13G | ORIC PHARMACEUTICALS INC ORIC | Nextech Crossover I GP S.a. r.l. | 7,162,637 8.400% | 1,876,923![]() (+35.51%) | Filing History |
| 2025-08-14 4:05 pm Unchanged | 2025-08-12 | 13D | ORIC PHARMACEUTICALS INC ORIC | SR One Capital Management, LLC | 4,615,384 4.750% | 0 (Unchanged) | Filing History |
| 2025-08-05 6:36 pm Purchase | 2025-07-29 | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital, LLC | 6,728,116 6.900% | 3,310,048![]() (+96.84%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock, Inc. BLK | 3,620,224 4.200% | -1,481,593![]() (-29.04%) | Filing History |
| 2025-06-05 5:17 pm Purchase | 2025-05-29 | 13D | ORIC PHARMACEUTICALS INC ORIC | SR One Capital Management, LLC | 4,615,384 5.400% | 4,615,384![]() (New Position) | Filing History |
| 2025-06-04 4:32 pm Purchase | 2025-05-29 | 13G | ORIC PHARMACEUTICALS INC ORIC | Point72 Asset Management, L.P. | 4,401,659 5.100% | 4,401,659![]() (New Position) | Filing History |
| 2025-05-30 4:35 pm Purchase | 2025-04-08 | 13G | ORIC PHARMACEUTICALS INC ORIC | Venrock Healthcare Capital Partners III, L.P. | 6,596,885 7.700% | 3,414,358![]() (+107.28%) | Filing History |
| 2025-05-15 5:47 pm Sale | 2025-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | Venrock Healthcare Capital Partners III, L.P. | 3,182,527 4.500% | -1,245,858![]() (-28.13%) | Filing History |
| 2025-05-15 4:35 pm Purchase | 2025-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | VIKING GLOBAL INVESTORS LP | 6,572,700 9.200% | 2,572,700![]() (+64.32%) | Filing History |
| 2025-05-15 09:42 am Sale | 2025-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | Frazier Life Sciences Public Fund, L.P. | 1,410,193 2.000% | -2,732,662![]() (-65.96%) | Filing History |

